NestmedicWAR:NST -0.30%36 Days Payable is 1,640.81 as of Mar. 2026, which is 160% above its 10-year median of 631.09. GuruFocus rates WAR:NST with a GF Score™ of 36/100 and a GF Value™ of zł0.42 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Nestmedic ranks better than 94.47% on this metric.
Nestmedic's average Accounts Payable for the
three
months ended in Mar. 2026 was zł0.49 Mil. Nestmedic's Cost of Goods Sold for the
three
months ended in Mar. 2026 was zł0.03 Mil.
Hence, Nestmedic's Days Payable for the
three
months ended in Mar. 2026 was 1,640.81.
The historical rank and industry rank for Nestmedic's Days Payable or its related term are showing as below:
WAR:NST'
s Days Payable Range Over the Past 10 Years
Min: 278.48 Med: 631.09 Max: 943.15
Current: 720.75
During the past 11 years, Nestmedic's highest Days Payable was 943.15. The lowest was 278.48. And the median was 631.09.
WAR:NST's Days Payable is ranked better than 94.47% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs WAR:NST: 720.75
Nestmedic's Days Payable
declined
from Mar. 2025 (1,779.38) to Mar. 2026 (1,640.81).
It may suggest that Nestmedicaccelerated paying its suppliers.
Nestmedic Days Payable Related Terms
Nestmedic Days Payable Historical Data
* Premium members only.
The historical data trend for Nestmedic's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nestmedic's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nestmedic Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nestmedic's Days Payable distribution charts can be found below:
* The bar in red indicates where Nestmedic's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Nestmedic's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nestmedic (WAR:NST) has a Days Payable of 1,640.81 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nestmedic and its competitors. This is 160% above median its historical median of 631.09. Over the past decade, Nestmedic's Days Payable has ranged from 278.48 to 943.15. According to the industry distribution chart, Nestmedic ranks #44 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 5.5%.
Is Nestmedic's Days Payable too high?
Nestmedic's current Days Payable of 1,640.81 is 160% above median its 10-year median of 631.09. Over the past 10 years, this metric has ranged from a low of 278.48 to a high of 943.15. The Medical Devices & Instruments industry median Days Payable is 68.07. Nestmedic's value of 1,640.81 is 2310.5% above this industry median. Based on the distribution chart, Nestmedic ranks #44 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Nestmedic has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nestmedic's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nestmedic ranks #44 out of 795 companies for Days Payable. This places Nestmedic in the top 6% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.07. Nestmedic's value of 1,640.81 is 2310.5% above this benchmark. Historically, Nestmedic's own Days Payable has ranged from 278.48 to 943.15 over the past decade. While the company's 10-year median is 631.09 vs. the industry median of 68.07, Nestmedic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nestmedic's current Days Payable of 1,640.81 is 2310.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Nestmedic and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nestmedic's current Days Payable is 1,640.81, which is 160% above median its own 10-year median of 631.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nestmedic stock overvalued right now?
Based on GuruFocus' analysis, Nestmedic (WAR:NST) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.42, compared to a current price of zł0.65 — trading 55.7% above its estimated fair value. The current Days Payable is 1,640.81, which is 160% above median its 10-year median of 631.09 and 2310.5% above the Medical Devices & Instruments industry median of 68.07. Nestmedic's overall GF Score™ is 36/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Nestmedic (WAR:NST), the current Days Payable is 1,640.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nestmedic (WAR:NST) Overvalued in 2026?
Based on GuruFocus' analysis, Nestmedic stock appears to be overvalued.
The current stock price of zł0.65 is trading 55.7% above its estimated GF Value™ of zł0.42.
GuruFocus considers Nestmedic to be Significantly Overvalued.
Key valuation signals for WAR:NST:
Days Payable: 1,640.81 (160% above median its 10-year median of 631.09)
GF Value™: zł0.42 vs. price of zł0.65 (55.7% above fair value)
Industry Position: 2310.5% above the Medical Devices & Instruments median (#44 of 795)
No single metric tells the full story. See the WAR:NST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nestmedic SA is a manufacturer of mobile telemedicine solution Pregnabit for remote fetal well-being - cardiotocographic (KTG). Pregnabit consists of a medical device (teleKTG) allowing to reliably and safely retrieve data using certified medical probes.
36GF Score
Get the complete analysis for WAR:NST
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:NST has been successfully added to your 
